首页 > 最新文献

Endokrinnaia khirurgiia最新文献

英文 中文
Insulinoma: analysis of prevalence and incidence in the world 胰岛素瘤:全球患病率和发病率分析
Pub Date : 2023-08-16 DOI: 10.14341/serg12805
M. Yu. Yukina, A. R. Elfimova, E. A. Troshina, G. A. Melnichenko, N. G. Mokrysheva
BACKGROUND : Currently, there are no data on the prevalence and incidence of insulinoma in Russia. The published world data on the epidemiology of the tumor are largely variable. Thus, it is important to systematize information on the prevalence and incidence of insulinoma in the world, including in Russia. AIM: To assess the prevalence and incidence of insulinoma in the world. TASKS Analysis of literature data. Analysis of the database of the Endocrinology Research Centre. MATERIALS AND METHODS : To implement Task 1, an analysis of foreign and Russian articles published in the PubMed and eLIBRARY.RU databases from 1927 was carried out until June 1, 2023, including the following keywords: «Insulinoma», «Epidemiology», «Frequency», «Incidence», «Nationwide», «Database». Based on the obtained results, an analysis of the prevalence and incidence of insulinoma in the world and in Russia was made. To implement Task 2, the analysis of patient records and the electronic database of the Endocrinology Research Centre was carried out. RESULTS : Based on data in individual countries the prevalence and incidence of insulinoma for the world population amounted to: an average of 16.4 per 1 million population and 0.9 per 1 million population per year, respectively. If extrapolating the world data, the number of patients with insulinoma in Russia can be 1066–2362 and 72–173 new cases are diagnosed annually (11.9 per 1 million population and 0.9 per 1 million population per year, respectively). The largest number of patients with insulinoma in Russia was recorded in the Endocrinology Research Centre and amounted to 275 cases for the period 2006–2022. CONCLUSION: In the Russian Federation, it is important to create a register of patients with insulinoma on the basis of the existing electronic database of the Endocrinology Research Centre in order to obtain accurate information about the current needs of patients with insulinoma in medical care and drug provision, as well as to conduct full-fledged scientific research.
背景:目前,没有关于俄罗斯胰岛素瘤患病率和发病率的数据。世界上发表的关于肿瘤流行病学的数据在很大程度上是可变的。因此,将包括俄罗斯在内的世界范围内胰岛素瘤的患病率和发病率信息系统化是很重要的。目的:了解世界范围内胰岛素瘤的患病率和发病率。文献资料分析。分析内分泌研究中心的数据库。材料和方法:为了完成任务1,对在PubMed和图书馆发表的外国和俄罗斯文章进行分析。从1927年至2023年6月1日的RU数据库,包括以下关键词:“Insulinoma”,“流行病学”,“频率”,“发病率”,“全国”,“数据库”。在此基础上,分析了世界和俄罗斯胰岛素瘤的患病率和发病率。为实现任务2,对患者病历和内分泌研究中心电子数据库进行分析。结果:根据个别国家的数据,世界人口的胰岛素瘤患病率和发病率分别为:平均每100万人16.4例和每年每100万人0.9例。如果外推世界数据,俄罗斯胰岛素瘤患者数量每年可达1066-2362例,新诊断病例72-173例(分别为11.9 / 100万人口和0.9 / 100万人口)。俄罗斯内分泌学研究中心记录的胰岛素瘤患者人数最多,2006-2022年期间共有275例。结论:在俄罗斯联邦,重要的是在内分泌学研究中心现有电子数据库的基础上建立胰岛素瘤患者登记册,以便获得关于胰岛素瘤患者在医疗和药物供应方面当前需求的准确信息,并开展全面的科学研究。
{"title":"Insulinoma: analysis of prevalence and incidence in the world","authors":"M. Yu. Yukina, A. R. Elfimova, E. A. Troshina, G. A. Melnichenko, N. G. Mokrysheva","doi":"10.14341/serg12805","DOIUrl":"https://doi.org/10.14341/serg12805","url":null,"abstract":"BACKGROUND : Currently, there are no data on the prevalence and incidence of insulinoma in Russia. The published world data on the epidemiology of the tumor are largely variable. Thus, it is important to systematize information on the prevalence and incidence of insulinoma in the world, including in Russia. AIM: To assess the prevalence and incidence of insulinoma in the world. TASKS Analysis of literature data. Analysis of the database of the Endocrinology Research Centre. MATERIALS AND METHODS : To implement Task 1, an analysis of foreign and Russian articles published in the PubMed and eLIBRARY.RU databases from 1927 was carried out until June 1, 2023, including the following keywords: «Insulinoma», «Epidemiology», «Frequency», «Incidence», «Nationwide», «Database». Based on the obtained results, an analysis of the prevalence and incidence of insulinoma in the world and in Russia was made. To implement Task 2, the analysis of patient records and the electronic database of the Endocrinology Research Centre was carried out. RESULTS : Based on data in individual countries the prevalence and incidence of insulinoma for the world population amounted to: an average of 16.4 per 1 million population and 0.9 per 1 million population per year, respectively. If extrapolating the world data, the number of patients with insulinoma in Russia can be 1066–2362 and 72–173 new cases are diagnosed annually (11.9 per 1 million population and 0.9 per 1 million population per year, respectively). The largest number of patients with insulinoma in Russia was recorded in the Endocrinology Research Centre and amounted to 275 cases for the period 2006–2022. CONCLUSION: In the Russian Federation, it is important to create a register of patients with insulinoma on the basis of the existing electronic database of the Endocrinology Research Centre in order to obtain accurate information about the current needs of patients with insulinoma in medical care and drug provision, as well as to conduct full-fledged scientific research.","PeriodicalId":30783,"journal":{"name":"Endokrinnaia khirurgiia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136337779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
To the 120th anniversary of the birth of Professor Oleg Vladimirovich Nikolaev (1903–1980) 纪念奥列格·弗拉基米罗维奇·尼古拉耶夫教授(1903-1980)诞辰120周年
Pub Date : 2023-07-02 DOI: 10.14341/serg12801
I. V. Kim, N. Nuralieva
.
{"title":"To the 120th anniversary of the birth of Professor Oleg Vladimirovich Nikolaev (1903–1980)","authors":"I. V. Kim, N. Nuralieva","doi":"10.14341/serg12801","DOIUrl":"https://doi.org/10.14341/serg12801","url":null,"abstract":"<jats:p>.</jats:p>","PeriodicalId":30783,"journal":{"name":"Endokrinnaia khirurgiia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49278182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In memory of Bondarenko Vladimir Olegovich (07.06.1960–15.08.2022) 纪念Bondarenko Vladimir Olegovich(1960年6月7日至2022年8月15日)
Pub Date : 2023-07-02 DOI: 10.14341/serg12802
I. V. Kim
.
{"title":"In memory of Bondarenko Vladimir Olegovich (07.06.1960–15.08.2022)","authors":"I. V. Kim","doi":"10.14341/serg12802","DOIUrl":"https://doi.org/10.14341/serg12802","url":null,"abstract":"<jats:p>.</jats:p>","PeriodicalId":30783,"journal":{"name":"Endokrinnaia khirurgiia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45324556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thyroid functional autonomy — sclerotherapy and radioactive iodine therapy: case report 甲状腺功能自主-硬化治疗与放射性碘治疗1例
Pub Date : 2023-06-09 DOI: 10.14341/serg12737
U. V. Buyvalenko, M. S. Sheremeta, I. V. Kim, A. A. Trukhin, M. O. Korchagina, N. Yu. Sviridenko
Thyroid functional autonomy (TFA) is the most frequent reasons of subclinical or manifest thyrotoxicosis. Diagnosis of the causes of thyrotoxicosis (destruction or increased functional activity of the thyroid tissue in nodular and diffuse thyroid pathology) is a key point in determining the management of patients with this pathology. Scintigraphy is the method of choice in differential diagnosis of the causes of thyrotoxicosis assessing the functional state of the thyroid gland. Thyroid scintigraphy can be performed using 99mTc-pertechnetate. After normalization of the level of thyroid hormones is confirmed, radical treatment is recommended. It could be surgery or radioactive iodine therapy (RAI). In some cases, especially in the elderly women, TFA is combined with thyroid nodules (TN), which can cause pressure symptoms, cosmetic complaints, and thyroid dysfunction. Minimally invasive treatments, such as percutaneous ethanol injection (PEI) sclerotherapy, has been proposed, especially for pressure symptoms and cosmetic complaints, as an alternative to surgery. The presented clinical case will demonstrate the possibility of use sclerotherapy and RAI for the successful treatment of TFA with TN.
甲状腺功能自主(TFA)是亚临床或显性甲状腺毒症最常见的原因。甲状腺毒症的病因诊断(结节性和弥漫性甲状腺病理中甲状腺组织的破坏或功能活性增加)是确定该病理患者治疗的关键。闪烁显像是鉴别诊断甲状腺毒症病因、评估甲状腺功能状态的首选方法。甲状腺显像可用99mtc - pertecnetate进行。甲状腺激素水平恢复正常后,建议进行根治性治疗。它可能是手术或放射性碘疗法(RAI)。在某些情况下,尤其是老年妇女,TFA合并甲状腺结节(TN),可引起压力症状、美容不适和甲状腺功能障碍。微创治疗,如经皮乙醇注射(PEI)硬化治疗,已被提议作为手术的替代方案,特别是对于压力症状和美容投诉。本临床病例将证明使用硬化疗法和RAI成功治疗TFA与TN的可能性。
{"title":"Thyroid functional autonomy — sclerotherapy and radioactive iodine therapy: case report","authors":"U. V. Buyvalenko, M. S. Sheremeta, I. V. Kim, A. A. Trukhin, M. O. Korchagina, N. Yu. Sviridenko","doi":"10.14341/serg12737","DOIUrl":"https://doi.org/10.14341/serg12737","url":null,"abstract":"Thyroid functional autonomy (TFA) is the most frequent reasons of subclinical or manifest thyrotoxicosis. Diagnosis of the causes of thyrotoxicosis (destruction or increased functional activity of the thyroid tissue in nodular and diffuse thyroid pathology) is a key point in determining the management of patients with this pathology. Scintigraphy is the method of choice in differential diagnosis of the causes of thyrotoxicosis assessing the functional state of the thyroid gland. Thyroid scintigraphy can be performed using 99mTc-pertechnetate. After normalization of the level of thyroid hormones is confirmed, radical treatment is recommended. It could be surgery or radioactive iodine therapy (RAI). In some cases, especially in the elderly women, TFA is combined with thyroid nodules (TN), which can cause pressure symptoms, cosmetic complaints, and thyroid dysfunction. Minimally invasive treatments, such as percutaneous ethanol injection (PEI) sclerotherapy, has been proposed, especially for pressure symptoms and cosmetic complaints, as an alternative to surgery. The presented clinical case will demonstrate the possibility of use sclerotherapy and RAI for the successful treatment of TFA with TN.","PeriodicalId":30783,"journal":{"name":"Endokrinnaia khirurgiia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135215403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-recurrent laryngeal nerve in thyroid and parathyroid surgery 喉非返神经在甲状腺和甲状旁腺手术中的应用
Pub Date : 2023-06-06 DOI: 10.14341/serg12788
A. A. Kuprin, N. N. Vetsheva, I. O. Abuladze
BACKGROUND : the main reason for postoperative vocal folds paresis is the variable anatomy of the recurrent laryngeal nerve. An example of such an “extreme form of embryonal development» is the non-recurrent laryngeal nerve. However, many surgeons consider this structure to be a rare anomaly with prevalence less than 0.5%. This opinion is associated with a six to seven-fold increase in the number of vocal folds paresis when a surgeon encounters with a non-recurrent laryngeal nerve. Meanwhile, in cadaveric studies a significantly higher prevalence of non-recurrent laryngeal nerve was demonstrated — 2.2%. The right aberrant subclavian artery was diagnosed during CT in 3.1% patients. AIM : the aim of the study is to determine the effectiveness of preoperative ultrasound in detecting the right aberrant subclavian artery and non-recurrent laryngeal nerve. MATERIALS AND METHODS : patients underwent thyroid and parathyroid surgery with identification of a right inferior laryngeal nerve. The preoperative neck ultrasound was performed on all patients with visualization of a brachiocephalic trunk (Y-sign) or a right aberrant subclavian artery (AL-sign). CT-angiography was performed in the postoperative period on patients who had a non-recurrent laryngeal nerve. RESULTS : the study included 1476 patients. The Y-sign was determined among 1338 (90.7%) patients. In these cases a typical anatomy of the recurrent laryngeal nerve was observed. In 138 (9.3%) cases, the Y-sign was not detected. In this subgroup of patients, in 20 (1.4%) cases, a non-recurrent laryngeal nerve and a right aberrant subclavian artery were noted. Thus, the sensitivity of the Y-sign in confirming the normal anatomy of the recurrent laryngeal nerve was 100%, specificity — 91.9%, positive prognostic value — 14.5%, negative prognostic value — 100%. On the contrary, AL-sign was notedall 20 (1.4%) patients with non-recurrent laryngeal nerve and right aberrant subclavian artery. False positive and false negative results were not observed. Three variants of the non-recurrent laryngeal nerve were identified: type I (superior type) — located behind the upper third of the thyroid lobe, has a direct descending way and forms an angle to the larynx of 30–50°; type III (inferior type) — has a direct ascending way (simulates the course of the recurrent laryngeal nerve) and forms an angle to trachea in 30–50°; type II (middle type) — all variants of the non-recurrent laryngeal nerve located between types I and III. CONCLUSION : the preoperative ultrasound detection of brachiocephalic trunk (Y-sign) confirms the presence of a recurrent laryngeal nerve (sensitivity 100%), and visualization of the right aberrant subclavian artery (AL-sign) determines a non-recurrent laryngeal nerve (sensitivity and specificity 100%).
背景:术后声带轻瘫的主要原因是喉返神经解剖结构的变化。这种“胚胎发育的极端形式”的一个例子是喉非返神经。然而,许多外科医生认为这种结构是罕见的异常,患病率低于0.5%。当外科医生遇到非喉返神经时,这种观点与声带轻瘫的数量增加6至7倍有关。同时,在尸体研究中,非喉返神经的患病率明显较高,为2.2%。3.1%的患者在CT中被诊断为右侧锁骨下动脉异常。目的:探讨术前超声对右侧异常锁骨下动脉及喉非返神经的检测效果。材料和方法:患者接受甲状腺和甲状旁腺手术,确定右喉下神经。术前颈部超声检查均可见头臂干(y征)或右侧异常锁骨下动脉(al征)。术后对有喉返神经的患者行ct血管造影。结果:纳入1476例患者。1338例(90.7%)患者有y征。在这些病例中,观察到典型的喉返神经解剖。138例(9.3%)未检出y型征象。在这一亚组患者中,20例(1.4%)患者出现喉非复发神经和右侧异常的锁骨下动脉。因此,y征在确认喉返神经解剖正常方面的敏感性为100%,特异性为91.9%,阳性预后值为14.5%,阴性预后值为100%。与此相反,喉非返神经及右侧锁骨下动脉异常的20例(1.4%)患者无al征。未见假阳性和假阴性结果。经鉴定,喉非返神经有三种变体:ⅰ型(上型)-位于甲状腺叶上三分之一后方,有直接下行,与喉成30-50°角;III型(下型)-有一个直接上升的方式(模拟喉返神经的路线),与气管形成一个30-50°的角度;II型(中间型)-位于I型和III型之间的所有非喉返神经变异。结论:术前超声检查头臂干(y征)确认喉返神经存在(敏感性100%),右侧异常锁骨下动脉(al征)可见非喉返神经存在(敏感性和特异性100%)。
{"title":"Non-recurrent laryngeal nerve in thyroid and parathyroid surgery","authors":"A. A. Kuprin, N. N. Vetsheva, I. O. Abuladze","doi":"10.14341/serg12788","DOIUrl":"https://doi.org/10.14341/serg12788","url":null,"abstract":"BACKGROUND : the main reason for postoperative vocal folds paresis is the variable anatomy of the recurrent laryngeal nerve. An example of such an “extreme form of embryonal development» is the non-recurrent laryngeal nerve. However, many surgeons consider this structure to be a rare anomaly with prevalence less than 0.5%. This opinion is associated with a six to seven-fold increase in the number of vocal folds paresis when a surgeon encounters with a non-recurrent laryngeal nerve. Meanwhile, in cadaveric studies a significantly higher prevalence of non-recurrent laryngeal nerve was demonstrated — 2.2%. The right aberrant subclavian artery was diagnosed during CT in 3.1% patients. AIM : the aim of the study is to determine the effectiveness of preoperative ultrasound in detecting the right aberrant subclavian artery and non-recurrent laryngeal nerve. MATERIALS AND METHODS : patients underwent thyroid and parathyroid surgery with identification of a right inferior laryngeal nerve. The preoperative neck ultrasound was performed on all patients with visualization of a brachiocephalic trunk (Y-sign) or a right aberrant subclavian artery (AL-sign). CT-angiography was performed in the postoperative period on patients who had a non-recurrent laryngeal nerve. RESULTS : the study included 1476 patients. The Y-sign was determined among 1338 (90.7%) patients. In these cases a typical anatomy of the recurrent laryngeal nerve was observed. In 138 (9.3%) cases, the Y-sign was not detected. In this subgroup of patients, in 20 (1.4%) cases, a non-recurrent laryngeal nerve and a right aberrant subclavian artery were noted. Thus, the sensitivity of the Y-sign in confirming the normal anatomy of the recurrent laryngeal nerve was 100%, specificity — 91.9%, positive prognostic value — 14.5%, negative prognostic value — 100%. On the contrary, AL-sign was notedall 20 (1.4%) patients with non-recurrent laryngeal nerve and right aberrant subclavian artery. False positive and false negative results were not observed. Three variants of the non-recurrent laryngeal nerve were identified: type I (superior type) — located behind the upper third of the thyroid lobe, has a direct descending way and forms an angle to the larynx of 30–50°; type III (inferior type) — has a direct ascending way (simulates the course of the recurrent laryngeal nerve) and forms an angle to trachea in 30–50°; type II (middle type) — all variants of the non-recurrent laryngeal nerve located between types I and III. CONCLUSION : the preoperative ultrasound detection of brachiocephalic trunk (Y-sign) confirms the presence of a recurrent laryngeal nerve (sensitivity 100%), and visualization of the right aberrant subclavian artery (AL-sign) determines a non-recurrent laryngeal nerve (sensitivity and specificity 100%).","PeriodicalId":30783,"journal":{"name":"Endokrinnaia khirurgiia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135601643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Difficulties and missteps of diagnosis and surgical treatment of patient with multifocal metachronic carcinoma associated with primary hyperparathyroidism 原发性甲状旁腺功能亢进伴多灶性变时性癌的诊断与手术治疗的困难与失误
Pub Date : 2023-06-02 DOI: 10.14341/serg12787
S. V. Sergiiko, D. V. Korotovskii, S. A. Lukyanov, O. G. Baturin, A. S. Butorin, T. E. Ilyina
We present a clinical case of a patient with metachronous primary multiple carcinoma of left kidney (2004) with left adrenal metastasis (2021), occult low-grade follicular thyroid carcinoma with lateral neck lymph node metastasis (2019), central lung cancer (2020), primary hyperparathyroidism with coherent parathyroid adenomas with intrathyroid and typical location. Patient had undergone left-side nephrectomy with bilateral adrenalectomy, double-staged thyroidectomy with parathyroidectomy and selective lateral neck dissection and right-side pulmonectomy with 4 sessions of chemotherapy. Almost 20 years after first operation patient has no signs of tumors recurrence. In addition, patient is undergoing hormone replacement therapy (HRT) of adrenal insufficiency and thyroid hormone suppression therapy. This case represents combination of non-hereditary endocrine neoplasms with multiple carcinomas. It also examples mistakes and difficulties of differential diagnosis of primary adrenal tumors and adrenal metastasis.
我们报告1例异时性原发性多发左肾癌(2004年)合并左肾上腺转移(2021年)、隐匿性低级别滤泡性甲状腺癌合并侧颈淋巴结转移(2019年)、中枢性肺癌(2020年)、原发性甲状旁腺功能亢合并甲状腺内一致性甲状旁腺瘤及典型部位。患者行左侧肾切除术+双侧肾上腺切除术,双期甲状腺切除术+甲状旁腺切除术,选择性侧颈清扫及右侧肺切除术,化疗4次。患者首次手术后近20年未见肿瘤复发迹象。此外,患者正在接受肾上腺功能不全的激素替代治疗(HRT)和甲状腺激素抑制治疗。本病例为非遗传性内分泌肿瘤合并多发性癌。并举例说明原发性肾上腺肿瘤和肾上腺转移瘤鉴别诊断的错误和困难。
{"title":"Difficulties and missteps of diagnosis and surgical treatment of patient with multifocal metachronic carcinoma associated with primary hyperparathyroidism","authors":"S. V. Sergiiko, D. V. Korotovskii, S. A. Lukyanov, O. G. Baturin, A. S. Butorin, T. E. Ilyina","doi":"10.14341/serg12787","DOIUrl":"https://doi.org/10.14341/serg12787","url":null,"abstract":"We present a clinical case of a patient with metachronous primary multiple carcinoma of left kidney (2004) with left adrenal metastasis (2021), occult low-grade follicular thyroid carcinoma with lateral neck lymph node metastasis (2019), central lung cancer (2020), primary hyperparathyroidism with coherent parathyroid adenomas with intrathyroid and typical location. Patient had undergone left-side nephrectomy with bilateral adrenalectomy, double-staged thyroidectomy with parathyroidectomy and selective lateral neck dissection and right-side pulmonectomy with 4 sessions of chemotherapy. Almost 20 years after first operation patient has no signs of tumors recurrence. In addition, patient is undergoing hormone replacement therapy (HRT) of adrenal insufficiency and thyroid hormone suppression therapy. This case represents combination of non-hereditary endocrine neoplasms with multiple carcinomas. It also examples mistakes and difficulties of differential diagnosis of primary adrenal tumors and adrenal metastasis.","PeriodicalId":30783,"journal":{"name":"Endokrinnaia khirurgiia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136084743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of sleeve gastrectomy on menstrual function and ovarian reserve in patients with obesity 袖状胃切除术对肥胖患者月经功能和卵巢储备的影响
Pub Date : 2023-05-03 DOI: 10.14341/serg12780
G. V. Semikova, S. Dora, Z. V. Shvets, E. A. Kulchitskaya, A. Volkova
BACKGROUND: Obesity is associated with development of menstrual disorders (MD), a decrease in ovarian reserve and infertility. Treatment of obesity contributes to the normalization of the reproductive function of women. Bariatric surgery is known to be the most effective method of obesity treatment, while the most common intervention is the sleeve gastrectomy (SG), the effect of which on menstrual function and ovarian reserve has not been studied enough.AIM: To study the effect of SG on menstrual function and ovarian reserve in obese women of reproductive ageMATERIALS AND METHODS: Female patients with BMI ≥ 35 kg/m2 aged 25 to 36 years were examined. At baseline and 6 months after SG, the characteristics of menstrual function were determined, BMI and HOMA-IR were calculated, and the level of anti-Müllerian hormone (AMH) was measured. The obtained parameters were compared in patients with and without MDRESULTS: . In all patients, 6 months after SG, there was a decrease in BMI: 30.1 kg/m2 (29.3–32.1) and 39.3 kg/m2 (37.3–41.0) (p<0.001), HOMA -IR: 5.0 (4.1–5.9) and 2.8 (2.1–3.2) (p=0.001). The initial level of AMH in patients with MD (n=12) was lower than in patients with normal menstrual function (n=10): 2.4 ng/ml (1.9–2.0) and 3.2 ng/ml (2.6–4.2), respectively (p=0.032). A significant increase in AMH levels occurred only in the group of patients with MD (p=0.04). MD remained only in 3 women.CONCLUSION: SG in patients of reproductive age with obesity is associated with the normalization of menstrual function and an increase in AMH, as well as a decrease in the degree of insulin resistance.
背景:肥胖与月经紊乱(MD)、卵巢储备功能下降和不孕有关。肥胖的治疗有助于女性生殖功能的正常化。减肥手术是治疗肥胖最有效的方法,而最常见的干预措施是袖式胃切除术(SG),其对月经功能和卵巢储备的影响尚未得到足够的研究。目的:研究SG对肥胖育龄女性月经功能及卵巢储备的影响。材料与方法:选取25 ~ 36岁BMI≥35 kg/m2的女性患者为研究对象。在基线和SG后6个月,测定月经功能特征,计算BMI和HOMA-IR,测定抗勒氏管激素(AMH)水平。将获得的参数在有和没有mre的患者中进行比较。在所有患者中,SG后6个月,BMI分别下降30.1 kg/m2(29.3-32.1)和39.3 kg/m2 (37.3-41.0) (p<0.001), HOMA -IR分别下降5.0(4.1-5.9)和2.8 (2.1-3.2)(p=0.001)。MD患者(n=12)的AMH初始水平低于月经功能正常患者(n=10):分别为2.4 ng/ml(1.9 ~ 2.0)和3.2 ng/ml (2.6 ~ 4.2) (p=0.032)。AMH水平的显著升高仅发生在MD患者组(p=0.04)。只有3名女性患有MD。结论:育龄肥胖患者SG与月经功能正常化、AMH升高、胰岛素抵抗程度降低有关。
{"title":"Influence of sleeve gastrectomy on menstrual function and ovarian reserve in patients with obesity","authors":"G. V. Semikova, S. Dora, Z. V. Shvets, E. A. Kulchitskaya, A. Volkova","doi":"10.14341/serg12780","DOIUrl":"https://doi.org/10.14341/serg12780","url":null,"abstract":"BACKGROUND: Obesity is associated with development of menstrual disorders (MD), a decrease in ovarian reserve and infertility. Treatment of obesity contributes to the normalization of the reproductive function of women. Bariatric surgery is known to be the most effective method of obesity treatment, while the most common intervention is the sleeve gastrectomy (SG), the effect of which on menstrual function and ovarian reserve has not been studied enough.AIM: To study the effect of SG on menstrual function and ovarian reserve in obese women of reproductive ageMATERIALS AND METHODS: Female patients with BMI ≥ 35 kg/m2 aged 25 to 36 years were examined. At baseline and 6 months after SG, the characteristics of menstrual function were determined, BMI and HOMA-IR were calculated, and the level of anti-Müllerian hormone (AMH) was measured. The obtained parameters were compared in patients with and without MDRESULTS: . In all patients, 6 months after SG, there was a decrease in BMI: 30.1 kg/m2 (29.3–32.1) and 39.3 kg/m2 (37.3–41.0) (p<0.001), HOMA -IR: 5.0 (4.1–5.9) and 2.8 (2.1–3.2) (p=0.001). The initial level of AMH in patients with MD (n=12) was lower than in patients with normal menstrual function (n=10): 2.4 ng/ml (1.9–2.0) and 3.2 ng/ml (2.6–4.2), respectively (p=0.032). A significant increase in AMH levels occurred only in the group of patients with MD (p=0.04). MD remained only in 3 women.CONCLUSION: SG in patients of reproductive age with obesity is associated with the normalization of menstrual function and an increase in AMH, as well as a decrease in the degree of insulin resistance.","PeriodicalId":30783,"journal":{"name":"Endokrinnaia khirurgiia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42661047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From the editorial office 来自编辑部
Pub Date : 2023-04-07 DOI: 10.14341/serg12791
N. S. Kuznetsov
.
{"title":"From the editorial office","authors":"N. S. Kuznetsov","doi":"10.14341/serg12791","DOIUrl":"https://doi.org/10.14341/serg12791","url":null,"abstract":".","PeriodicalId":30783,"journal":{"name":"Endokrinnaia khirurgiia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135792798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Draft of clinical guidelines for the diagnosis and treatment of primary hyperparathyroidism in adult patients 成人原发性甲状旁腺功能亢进症诊断和治疗临床指南草案
Pub Date : 2023-04-07 DOI: 10.14341/serg12790
I. Dedov, G. Melnichenko, N. Mokrysheva, E. Andreeva, M. Antsiferov, D. G. Beltsevich, E. Bibik, A. Gorbacheva, M. V. Degtyarev, L. V. Yeghshatyan, A. Eremkina, T. L. Karonova, I. V. Kim, J. Krupinova, I. Kryukova, N. Kuznetsov, S. V. Lukyanov, E. Mamedova, N. V. Markina, S. Mirnaya, E. Pigarova, L. Rozhinskaya, K. Slashchuk, I. Sleptsov, N. B. Chagai
The article presents a draft of clinical recommendations for the diagnosis and treatment of primary hyperparathyroidism in adult patients, which provides a modern examination algorithm, discusses the basic principles of laboratory, instrumental diagnostics and treatment approaches.
本文提出了一份成人原发性甲状旁腺功能亢进症诊断和治疗的临床建议草案,该草案提供了一种现代检查算法,讨论了实验室、仪器诊断和治疗方法的基本原则。
{"title":"Draft of clinical guidelines for the diagnosis and treatment of primary hyperparathyroidism in adult patients","authors":"I. Dedov, G. Melnichenko, N. Mokrysheva, E. Andreeva, M. Antsiferov, D. G. Beltsevich, E. Bibik, A. Gorbacheva, M. V. Degtyarev, L. V. Yeghshatyan, A. Eremkina, T. L. Karonova, I. V. Kim, J. Krupinova, I. Kryukova, N. Kuznetsov, S. V. Lukyanov, E. Mamedova, N. V. Markina, S. Mirnaya, E. Pigarova, L. Rozhinskaya, K. Slashchuk, I. Sleptsov, N. B. Chagai","doi":"10.14341/serg12790","DOIUrl":"https://doi.org/10.14341/serg12790","url":null,"abstract":"The article presents a draft of clinical recommendations for the diagnosis and treatment of primary hyperparathyroidism in adult patients, which provides a modern examination algorithm, discusses the basic principles of laboratory, instrumental diagnostics and treatment approaches.","PeriodicalId":30783,"journal":{"name":"Endokrinnaia khirurgiia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42801748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Draft of clinical guidelines for the diagnosis and treatment of medullary thyroid cancer in adult patients 成人甲状腺髓样癌的诊断和治疗临床指南草案
Pub Date : 2023-04-07 DOI: 10.14341/serg12794
N. Severskaya, E. Choinzonov, I. Reshetov, S. A. Ivanov, A. Polyakov, M. Kropotov, A. Mudunov, V. Polkin, P. Isaev, A. Ilyin, D. G. Beltsevich, V. Vanushko, P. Rumyantsev, G. Melnichenko, Y. Alymov, I. S. Romanov, A. V. Ignatova, E. Borodavina, V. Krylov, A. Shurinov, Z. Radjabova, D. Kulbakin, A. Nevolskikh, A. Gevorkov, E. Khmelevsky, S. Kutukova, A. Guz, I. Sleptsov, R. Chernikov, A. Stepanova, N. Falaleeva, S. Podvyaznikov, N. Rubtsova, A. N. Rudyk, S. Musin, I. Gulidov, L. Vladimirova, T. Semiglazova, T. A. Aghababyan, E. Kostromina
The article presents a draft of clinical recommendations for the diagnosis and treatment of medullary thyroid cancer in adult patients, which provides a modern examination algorithm, discusses the basic principles of laboratory, instrumental diagnostics and treatment approaches.
本文提出了一份成人甲状腺髓样癌的临床诊断和治疗建议草案,提供了一种现代检查算法,讨论了实验室的基本原则,仪器诊断和治疗方法。
{"title":"Draft of clinical guidelines for the diagnosis and treatment of medullary thyroid cancer in adult patients","authors":"N. Severskaya, E. Choinzonov, I. Reshetov, S. A. Ivanov, A. Polyakov, M. Kropotov, A. Mudunov, V. Polkin, P. Isaev, A. Ilyin, D. G. Beltsevich, V. Vanushko, P. Rumyantsev, G. Melnichenko, Y. Alymov, I. S. Romanov, A. V. Ignatova, E. Borodavina, V. Krylov, A. Shurinov, Z. Radjabova, D. Kulbakin, A. Nevolskikh, A. Gevorkov, E. Khmelevsky, S. Kutukova, A. Guz, I. Sleptsov, R. Chernikov, A. Stepanova, N. Falaleeva, S. Podvyaznikov, N. Rubtsova, A. N. Rudyk, S. Musin, I. Gulidov, L. Vladimirova, T. Semiglazova, T. A. Aghababyan, E. Kostromina","doi":"10.14341/serg12794","DOIUrl":"https://doi.org/10.14341/serg12794","url":null,"abstract":"The article presents a draft of clinical recommendations for the diagnosis and treatment of medullary thyroid cancer in adult patients, which provides a modern examination algorithm, discusses the basic principles of laboratory, instrumental diagnostics and treatment approaches.","PeriodicalId":30783,"journal":{"name":"Endokrinnaia khirurgiia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47166797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Endokrinnaia khirurgiia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1